[HTML][HTML] Cyclooxygenase-1 (COX-1) and COX-1 inhibitors in cancer: A review of oncology and medicinal chemistry literature

A Pannunzio, M Coluccia - Pharmaceuticals, 2018 - mdpi.com
Prostaglandins and thromboxane are lipid signaling molecules deriving from arachidonic
acid by the action of the cyclooxygenase isoenzymes COX-1 and COX-2. The role of …

The role of cyclooxygenase‐2 in cell proliferation and cell death in human malignancies

C Sobolewski, C Cerella, M Dicato… - … journal of cell …, 2010 - Wiley Online Library
It is well admitted that the link between chronic inflammation and cancer involves cytokines
and mediators of inflammatory pathways, which act during the different steps of …

Potential utility of COX-2 inhibitors in chemoprevention and chemotherapy

AT Koki, KM Leahy, JL Masferrer - Expert opinion on …, 1999 - Taylor & Francis
Increased prostaglandin (PG) production is associated with many inflammatory
pathophysiological conditions; it is derived from arachidonic acid by either of two enzymes …

Cyclooxygenases in cancer: progress and perspective

S Zha, V Yegnasubramanian, WG Nelson, WB Isaacs… - Cancer letters, 2004 - Elsevier
Aspirin has been used to control pain and inflammation for over a century. Epidemiological
studies first associated a decreased incidence of colorectal cancer with the long-term use of …

Biology of Cox-2: an application in cancer therapeutics

Z Khan, N Khan, RP Tiwari, NK Sah… - Current drug …, 2011 - ingentaconnect.com
Cyclooxygenase-2 (Cox-2) is an inducible enzyme involved in the conversion of arachidonic
acid to prostaglandin and other eicosanoids. Molecular pathology studies have revealed …

Many actions of cyclooxygenase‐2 in cellular dynamics and in cancer

Y Cao, SM Prescott - Journal of cellular physiology, 2002 - Wiley Online Library
Abstract Cyclooxygenase‐2 (COX‐2) is the inducible isoform of cyclooxygenase, the
enzyme that catalyzes the rate‐limiting step in prostaglandin synthesis from arachidonic …

Discovery and design of selective cyclooxygenase-2 inhibitors as non-ulcerogenic, anti-inflammatory drugs with potential utility as anti-cancer agents

AS Kalgutkar, Z Zhao - Current Drug Targets, 2001 - ingentaconnect.com
The recent marketing of two selective cyclooxygenase-2 (COX-2) inhibitors, celecoxib and
rofecoxib is remarkable considering that COX-2 was only discovered eight years ago as a …

Biochemistry of cyclooxygenase (COX)-2 inhibitors and molecular pathology of COX-2 in neoplasia

E Fosslien - Critical reviews in clinical laboratory sciences, 2000 - Taylor & Francis
Several types of human tumors overexpress cyclooxygenase (COX)-2 but not COX-1, and
gene knockout transfection experiments demonstrate a central role of COX-2 in …

Influencing COX-2 activity by COX related pathways in inflammation and cancer

T Yu, X Lao, H Zheng - Mini reviews in medicinal chemistry, 2016 - ingentaconnect.com
Cancer is a major cause of death worldwide despite significant advances in surgery and
biology. Several recent studies have suggested that there is a close connection between …

Cyclooxygenase‐2 in gastrointestinal malignancies

GP Nagaraju, BF El‐Rayes - Cancer, 2019 - Wiley Online Library
Cyclooxygenase (COX) is an enzyme complex that plays an important role in the conversion
of arachidonic acid to prostaglandins. Prostaglandins are essential modulators of signal …